Logo

Mitsubishi To Sell Waban Software in Japan

Sep 11, 2006
NEW YORK (GenomeWeb News) - Mitsubishi Space Software will sell Waban Software’s Waban Explorer PGx and Waban SCE in Japan, the companies said today.
 
Financial terms of the deal were not disclosed.
 
In a statement, Himanshu Oberoi, president of Waban, said the deal grew out of the global growth of clinical pharmacogenomics, biomarker development and personalized medicine and the increased demand in Asia for Waban products.
 
Waban Explorer PGx provides a secure, 21 CFR11-compliant platform for integrating multiple data sources “and enables exploring, browsing, querying and running analyses using multiple analysis tools,” the company said.
 
Waban SCE offers a controlled environment for managing analyses and reporting in a 21 CFR11-compliant manner with a full audit trail and traceability, Waban added.

Filed under

Informatics
Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.